YACOUB, MONA-RITA
 Distribuzione geografica
Continente #
EU - Europa 2.554
AS - Asia 2.366
NA - Nord America 1.699
SA - Sud America 383
AF - Africa 42
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 7.063
Nazione #
US - Stati Uniti d'America 1.608
RU - Federazione Russa 1.559
SG - Singapore 967
CN - Cina 746
IT - Italia 390
BR - Brasile 314
HK - Hong Kong 253
VN - Vietnam 193
DE - Germania 142
FR - Francia 120
GB - Regno Unito 91
SE - Svezia 64
IN - India 61
NL - Olanda 55
CA - Canada 51
FI - Finlandia 34
MX - Messico 28
TR - Turchia 23
AR - Argentina 22
BD - Bangladesh 22
AT - Austria 19
PL - Polonia 19
ES - Italia 18
JP - Giappone 17
IQ - Iraq 16
AU - Australia 15
ZA - Sudafrica 15
ID - Indonesia 11
CL - Cile 10
CO - Colombia 10
EC - Ecuador 9
JO - Giordania 7
SA - Arabia Saudita 7
CH - Svizzera 6
MA - Marocco 6
PK - Pakistan 6
PY - Paraguay 6
DZ - Algeria 5
GR - Grecia 5
LT - Lituania 5
PH - Filippine 5
TN - Tunisia 5
UA - Ucraina 5
HN - Honduras 4
KE - Kenya 4
PT - Portogallo 4
VE - Venezuela 4
IE - Irlanda 3
MY - Malesia 3
PE - Perù 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
BW - Botswana 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
PS - Palestinian Territory 2
RO - Romania 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
PW - Palau 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.063
Città #
Singapore 550
Moscow 347
Ashburn 283
Dallas 260
Hong Kong 251
San Jose 222
Shanghai 151
Milan 107
Hefei 102
New York 95
Beijing 92
Lauterbourg 85
Ho Chi Minh City 63
Los Angeles 63
Boardman 43
Hanoi 36
Munich 35
São Paulo 34
Rome 32
Shenzhen 29
Guangzhou 28
Nuremberg 28
Orem 27
Cesano Boscone 23
Chennai 23
Santa Clara 23
Helsinki 21
Amsterdam 18
Brooklyn 18
Denver 18
London 18
Lawrence 16
Princeton 16
Atlanta 15
Boston 15
Chicago 15
Montreal 15
Toronto 15
Warsaw 15
Mexico City 14
Stockholm 14
Tokyo 14
Biên Hòa 13
Houston 13
Poplar 13
Rio de Janeiro 13
Council Bluffs 12
Jiaxing 12
Mumbai 11
San Francisco 11
Bologna 9
Brisbane 9
Falkenstein 9
Frankfurt am Main 9
Lappeenranta 9
Wuxi 9
Ankara 8
Belo Horizonte 8
Buenos Aires 8
Buffalo 8
Calgary 8
City of London 8
Haiphong 8
Johannesburg 8
Manchester 8
Padova 8
Phoenix 8
St Petersburg 8
Vienna 8
Washington 8
Amman 7
Contagem 7
Da Nang 7
Cleveland 6
Curitiba 6
Milwaukee 6
Querétaro 6
The Dalles 6
Wolfhagen 6
Brasília 5
Cologne 5
Dhaka 5
Florence 5
Guayaquil 5
Hải Dương 5
Jakarta 5
Naples 5
Quanzhou 5
Santiago 5
Seattle 5
Xi'an 5
Athens 4
Baghdad 4
Campo Grande 4
Changsha 4
Gatchina 4
Hangzhou 4
Lucerne 4
Mönchengladbach 4
Nairobi 4
Totale 3.706
Nome #
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 203
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 159
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan 149
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 142
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 138
Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps 122
Evolving Clinical Manifestations and Symptom Clusters in Long-COVID Patients: a Comparative Analysis from April 2020 to Present 119
Severe asthma: One disease and multiple definitions 118
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 118
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 117
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review 110
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases 108
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 108
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 108
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI ) 107
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 107
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 107
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 107
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis 106
Early increase in eosinophil count may predict long-term hypereosinophilia during dupilumab treatment: a 2-year observational study 105
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 105
A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation 103
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients 103
Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results 102
Characteristics and treatment regimens across ERS SHARP severe asthma registries 102
Assessment of impairment/disability due to occupational asthma through a multidimensional approach 98
The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey 95
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 93
IgE response to Aed al 13 and Aed al 14 recombinant allergens from Aedes albopictus saliva in humans 87
Asthma caused by cyanoacrylate used in a leisure activity [2] 85
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach 85
Caring with compassion during COVID-19 85
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 83
CLINICAL AND EPIDEMIOLOGICAL RELEVANCE OF ALLERGY IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN OBSERVATIONAL STUDY 83
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process 82
Capitolo 80: Malattie allergiche 80
Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis 80
Anisakis hypersensitivity in Italy: prevalence and clinical features: a multicenter study 78
Chronic rhinosinusitis with nasal polyps: a pilot study on immunologic dysregulation and the role of sensitisation to aeroallergens 77
Do environmental measures improve quality of life in mite-induced allergic rhinitis? 76
SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media 75
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 74
Hypersensitivity reactions to iodinated contrast media in Italy: a retrospective study. Characteristics of patients and risk factors 73
Occupational asthma and occupational rhinitis in hairdressers 72
EAACI position paper on occupational rhinitis 67
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 67
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 67
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 66
Post-COVID-19 follow-up clinic: Depicting chronicity of a new disease 65
Drug induced exfoliative dermatitis: State of the art 62
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 61
ITALIAN STUDY ON BUCKWHEAT ALLERGY: PREVALENCE AND CLINICAL FEATURES OF BUCKWHEAT-SENSITIZED PATIENTS IN ITALY 61
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 60
Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy 59
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 59
Eosinophils from Physiology to Disease: A Comprehensive Review 59
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A SINGLE CENTRE REAL-LIFE EXPERIENCE 58
HYPERSENSITIVITY TO RITUXIMAB: A RAPID AND SIMPLIFIED DESENSITIZATION PROTOCOL FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND OTHER AUTOIMMUNE DISORDERS 57
Systemic allergic reactions induced by labile plant-food allergens: Seeking potential cofactors. A multicenter study 57
Optimal management of DRESS syndrome in course of infectious endocarditis. 57
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus 55
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study 55
World Trade Center disaster: Short- and medium-term health outcome 53
Occupational rhinitis 53
IgG4-related disease and allergen-specific immunotherapy 53
Effects of sublingual immunotherapy on allergic inflammation: An update 52
Guidelines for the use and interpretation of diagnostic methods in adult food allergy 51
Unusual presentation of a serum sickness-like reaction due to sulfonamides 51
Occupational asthma due to bethabara wood dust 51
Is itIt's it possible to continue a really effective therapy in a patient with a severe hypersensitivity drug reaction? The importance of desensitization procedures in the monoclonal antibodies era 50
Occupational eosinophilic bronchitis 50
Pulmonary rehabilitation as evaluated by clinical trials: An overview 50
Subacute cutaneous Lupus erythematosus induced by dupilumab: a novel possible association with specific pathogenetic mechanisms 50
Resuscitation fluids 49
Usefulness of basophil activation test in gluten sensitivity 49
Omega-5 gliadin anaphylaxis: An integrated diagnostic approach 48
Immune mechanisms of allergen-specific immunotherapy 48
Incidence and characteristics of hospital-acquired pneumonia in a pulmonary rehabilitation setting 47
Effects of sublingual immunotherapy on allergic inflammation 47
Usefulness of induced sputum in investigating occupational asthma with normal responsiveness to methacholine: A case report 46
Safety of sublingual immunotherapy started during the pollen season 46
Usefulness of autologous serum and plasma skin tests in the diagnostic pathway of chronic idiopatic urticaria and/or autoimmune diseases and/or multiple drug allergy 45
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study 45
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests 45
Histamine release test correlates with disease activity in chronic spontaneous urticaria 44
Erratum to "Guidelines for the use and interpretation of diagnostic methods in adult food allergy". [Clin Mol Allergy, 13, (2015), 27] DOI: 10.1186/s12948-015-0033-9 44
Multiple drug hypersensivity: Insight into the underlying mechanism and correlation with autoimmune diseases 44
Wheat gastrointestinal hypersensitivity: a case report 43
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media. 43
Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium 42
Usefulness of skin testing in preventing hypersensitivity to iodinated contrast media 42
Is it possible to continue a really effective therapy in a patient with a severe hypersensitivity drug reaction? 41
Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis 41
Effect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order 40
Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor 40
Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience 38
Evaluation of basophil activation test in suspected food hypersensitivity 32
Six-minute walk test cut-off value identifying COPD patients with physical disability: A pilot study 31
Chronic urticaria: Not only after COVID-19 vaccination 5
From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis 2
Totale 7.277
Categoria #
all - tutte 32.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202251 0 0 7 7 2 4 4 4 7 1 11 4
2022/2023116 35 24 9 0 2 15 7 8 3 3 4 6
2023/2024523 2 7 18 150 12 83 29 38 5 16 25 138
2024/20251.783 207 39 36 101 209 152 159 179 276 181 123 121
2025/20264.790 371 353 278 637 492 192 546 362 1.342 217 0 0
Totale 7.279